The Prolia is for use in postmenopausal women with osteoporosis at a high risk of fractures. Approximately half of women older than 50 will have an osteoporosis-related fracture in their lifetime, according to an HHS study.
The financial terms of the deal were not disclosed.
More Articles on Devices:
8 Recent Leadership & Executive Moves at Spine, Orthopedic Device Companies
FDA Grants Approval to OsteoSelect Putty for Spinal Fusions
Renaissance Spine Guidance Brings 99% Accuracy to 118 Minimally Invasive Procedures in Germany
